benzothiazole has been researched along with Breast Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Meguid, EA; Awad, HM; El Kerdawy, AM; Moustafa, GO; Naglah, AM | 1 |
| Chang, Y; Choi, EJ; Do, SH; Jung, KH; Kim, HJ; Kim, HK; Kim, JY; Kim, KM; Kim, MH; Lee, KC; Lee, YJ; Oh, S; Park, JA | 1 |
| Bříza, T; Kejík, Z; Král, V; Králová, J; Martásek, P; Mikula, I; Poučková, P | 1 |
| Hu, C; Lee, H; Solomon, VR | 1 |
| Bradshaw, TD; Browne, HL; Laughton, CA; O'Brien, SE; Stevens, MF; Westwell, AD | 1 |
| Bradshaw, TD; Fichtner, I; Lelieveld, P; McCall, CJ; Shi, DF; Stevens, MF; Wrigley, S | 1 |
| Bradshaw, TD; Chua, MS; Shi, DF; Stevens, MF; Westwell, AD | 1 |
1 review(s) available for benzothiazole and Breast Cancer
| Article | Year |
|---|---|
Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Topics: Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Liver Neoplasms; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Quantitative Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
6 other study(ies) available for benzothiazole and Breast Cancer
| Article | Year |
|---|---|
Image-Guided Neutron Capture Therapy Using the Gd-DO3A-BTA Complex as a New Combinatorial Treatment Approach.
Topics: Animals; Benzothiazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Gadolinium; Heterografts; Humans; Magnetic Resonance Imaging; Mice; Neutron Capture Therapy; Tumor Burden | 2018 |
New method for recognition of sterol signalling molecules: methinium salts as receptors for sulphated steroids.
Topics: Animals; Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Carbocyanines; Cholesterol Esters; Estrone; Female; Heterocyclic Compounds; Mice, Nude; Pregnenolone; Xenograft Model Antitumor Assays | 2015 |
Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity.
Topics: Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Isatin; Thiazoles | 2009 |
Antitumor benzothiazoles. Frontier molecular orbital analysis predicts bioactivation of 2-(4-aminophenyl)benzothiazoles to reactive intermediates by cytochrome P4501A1.
Topics: Antineoplastic Agents; Benzothiazoles; Binding Sites; Biotransformation; Breast Neoplasms; Cations; Cell Death; Cytochrome P-450 CYP1A1; DNA Adducts; Dose-Response Relationship, Drug; Female; Humans; Hydrocarbons, Fluorinated; Models, Molecular; Oxidation-Reduction; Thiazoles; Tumor Cells, Cultured | 2003 |
Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Benzimidazoles; Benzothiazoles; Benzoxazoles; Breast Neoplasms; Cell Division; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Metallothionein 3; Mice; Mice, Nude; Structure-Activity Relationship; Thiazoles; Transplantation, Heterologous | 1996 |
Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivatives.
Topics: Amines; Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Drug Stability; Enzyme Activators; Female; Guanylate Cyclase; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Platelet Aggregation Inhibitors; Prodrugs; Solubility; Sulfonic Acids; Thiazoles; Tumor Cells, Cultured | 2001 |